Table 2. Enrichment of GO Biological Process Terms.
GO ID | GO Name | 240-OxSa | 173-OxSb | 121-OxSc | Quantifiedd | ||||
---|---|---|---|---|---|---|---|---|---|
| |||||||||
number genes | p-valuee | number genes | p-valuee | number genes | p-valuee | genes | number genes | ||
GO:0042776 | mitochondrial ATP synthesis coupled proton transport | 11 | < 1.0E-17 | 10 | 1.20E-14 | 10 | < 1.0E-17 | ATP5A1, ATP5B, ATP5C1, ATP5D, ATP5F1, ATP5H, ATP5I, ATP5J, ATP5L, ATP5O | 11 |
GO:0090382 | phagosome maturation | 11 | 3.05E-11 | 11 | 9.44E-13 | 11 | 7.11E-15 | ATP6V0A1, ATP6V0D1, ATP6V1A, ATP6V1B2, ATP6V1C1, ATP6V1D, ATP6V1E1, ATP6V1F, ATP6V1G1, ATP6V1H, TCIRG1 | 16 |
GO:0033572 | transferrin transport | 11 | 2.71E-10 | 11 | 8.72E-12 | 11 | 6.83E-14 | ATP6V0A1, ATP6V0D1, ATPGV1A, ATP6V1B2, ATP6V1C1, ATP6V1D, ATP6V1E1, ATP6V1F, ATP6V1G1, ATP6V1H, TCIRG1 | 18 |
GO:0008286 | insulin receptor signaling pathway | 13 | 1.53E-08 | 12 | 4.48E-09 | 11 | 5.32E-10 | ATP6V0A1, ATP6V0D1, ATP6V1A, ATP6V1B2, ATP6V1C1, ATP6V1D, ATP6V1E1, ATP6V1F, ATP6V1G1, ATP6V1H, TCIRG1 | 32 |
GO:0055085 | transmembrane transport | 54 | 1.95E-10 | 45 | 1.56E-10 | 34 | 8.40E-10 | ABCC4, ATP5A1, ATP5B, ATP5C1, ATP5D, ATP5F1, ATP5H, ATP5I, ATP5J, ATP5L, ATP50, ATP6V0A1, ATP6V0D1, ATP6V1A, ATP6V1B2, ATP6V1C1, ATP6V1D, ATP6V1E1, ATP6V1F, ATP6V1G1, ATP6V1H, CCT8, FTH1, FTL, HK1, HMOX1, HSPA1A, HSPA4, L0NP1, PSMD6, RPS27A, SLC39A7, TCIRG1, THBS1 | 313 |
GO:0051084 | ‘de novo’ posttranslational protein folding | 10 | 4.69E-06 | 10 | 2.58E-07 | 9 | 6.00E-08 | CCT2, CCT3, CCT4, CCT5, CCT6A, CCT7, CCT8, HSPH1, TCP1 | 30 |
GO:0022904 | respiratory electron transport chain | 15 | 1.38E-04 | 12 | 2.93E-04 | 12 | 4.21E-06 | ATP5A1, ATP5B, ATP5C1, ATP5D, ATP5F1, ATP5H, ATP5I, ATP5J, ATP5L, ATP5O, SDHA, SDHB | 78 |
GO:0043066 | negative regulation of apoptotic process | 41 | 1.65E-14 | 29 | 6.69E-10 | 15 | 1.77E-04 | AURKB, CEBPB, HMOX1, HSPA1A, HSPA9, POR, PSMD11, PSMD5, PSMD6, RPS27A, SERPINE1, SET, SQSTM1, THBS1, TIMP1 | 156 |
GO:0007264 | small GTPase mediated signal transduction | 19 | 2.30E-04 | 15 | 5.10E-04 | 9 | 1.00E-02 | FARP1, HMOX1, IQGAP1, KIF14, RAB2A, RAB5A, RAB5B, RND3, SQSTM1 | 115 |
GO:0055114 | oxidation-reduction process | 28 | 2.07E-01 | 22 | 1.64E-01 | 20 | 1.10E-02 | ABCC4, ALDH18A1, CYB5B, CYB5R3, ECH1, ETHE1, FTH1, GPD2, HADHA, HCCS, HK1, HMOX1, IQGAP1, POR, PTGS1, PYCR1, RPS27A, SDHA, SDHB, SQRDL | 334 |
GO:0006936 | muscle contraction | 6 | 8.04E-02 | 5 | 6.18E-02 | 5 | 1.11E-02 | CALD1, CNN1, MYOF, TPM3, TPM4 | 51 |
GO:0007155 | cell adhesion | 18 | 9.75E-03 | 13 | 2.92E-02 | 10 | 1.85E-02 | ATP5B, COL1A1, KIF14, LGALS1, MFGE8, RND3, SERPINE1, TGFBI, THBS1, TPM4 | 145 |
GO:0006986 | response to unfolded protein | 8 | 3.75E-02 | 7 | 2.03E-02 | 5 | 2.71E-02 | ATP6V0D1, HSPA1A, HSPA4, HSPH1, THBS1 | 62 |
GO:0000209 | protein polyubiquitination | 21 | 2.75E-10 | 17 | 4.42E-09 | 5 | 3.11E-02 | PSMD11, PSMD5, PSMD6, RPS27A, UBR5 | 64 |
Full set of 121-OxS nodes plus 119 suggested nodes from STRING.
Set of 121-OxS nodes plus 52 nodes suggested by STRING that were quantified.
Set of 121-OxS nodes.
Total number of quantified proteins annotated to the indicated process.
Hypergeometric p values calculated relative to the background of MS quantified proteins.